Effects of 17β-Estradiol on Colonic Permeability and Inflammation in an Azoxymethane/Dextran Sulfate Sodium-Induced Colitis Mouse Model

키워드

참고문헌 (64)

1. Siegel RL, "Cancer statistics, 2018", CA Cancer J Clin, 68, pp.7~30 (2018)
2. 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014", Cancer Research and Treatment, 49(2), pp.292~305 (2017), 대한암학회
3. Danese S, "Colitis-associated cancer: the dark side of inflammatory bowel disease", Gut, 60, pp.1609~1610 (2011)
4. Popivanova BK, "Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis", J Clin Invest, 118, pp.560~570 (2008)
5. Grivennikov S, "IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitisassociated cancer", Cancer Cell, 15, pp.103~113 (2009)
6. Tanaka T, "A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate", Cancer Sci, 94, pp.965~973 (2003)
7. Suzuki R, "Sequential observations on the occurrence of preneoplastic and neoplastic lesions in mouse colon treated with azoxymethane and dextran sodium sulfate", Cancer Sci, 95, pp.721~727 (2004)
8. Thaker AI, "Modeling colitisassociated cancer with azoxymethane (AOM) and dextran sulfate sodium (DSS)", J Vis Exp, (67), pp.4100~ (2012)
9. Tardieu D, "Dextran sulfate enhances the level of an oxidative DNA damage biomarker, 8-oxo-7,8-dihydro-2’-deoxyguanosine, in rat colonic mucosa", Cancer Lett, 134, pp.1~5 (1998)
10. De Robertis M, "The AOM", DSS murine model for the study of colon carcinogenesis: from pathways to diagnosis and therapy studies, 2011, pp.10, 9~
11. Suzuki R, "Strain differences in the susceptibility to azoxymethane and dextran sodium sulfate-induced colon carcinogenesis in mice", Carcinogenesis, 27, pp.162~169 (2006)
12. Shan M, "Mucus enhances gut homeostasis and oral tolerance by delivering immunoregulatory signals", Science, 342, pp.447~453 (2013)
13. Johansson ME, "Mucus layers in inflammatory bowel disease", Inflamm Bowel Dis, 20, pp.2124~2131 (2014)
14. Fishman JE, "The intestinal mucus layer is a critical component of the gut barrier that is damaged during acute pancreatitis", Shock, 42, pp.264~270 (2014)
15. Krug SM, "Tight junction, selective permeability, and related diseases", Semin Cell Dev Biol, 36, pp.166~176 (2014)
16. Wehkamp J, "Barrier dysfunction due to distinct defensin deficiencies in small intestinal and colonic Crohn’s disease", Mucosal Immunol, 1(Suppl 1), pp.S67~S74 (2008)
17. Wrzosek L, "Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent", BMC Biol, 11, pp.61~ (2013)
18. Ulluwishewa D, "Regulation of tight junction permeability by intestinal bacteria and dietary components", J Nutr, 141, pp.769~776 (2011)
19. Groschwitz KR, "Intestinal barrier function: molecular regulation and disease pathogenesis", J Allergy Clin Immunol, 124, pp.3~20 (2009)
20. Velcich A, "Colorectal cancer in mice genetically deficient in the mucin Muc2", Science, 295, pp.1726~1729 (2002)
21. Yang K, "Interaction of Muc2 and Apc on Wnt signaling and in intestinal tumorigenesis: potential role of chronic inflammation", Cancer Res, 68, pp.7313~7322 (2008)
22. Das S, "Mice deficient in Muc4 are resistant to experimental colitis and colitis-associated colorectal cancer", Oncogene, 35, pp.2645~2654 (2016)
23. 이성희, "Intestinal Permeability Regulation by Tight Junction: Implication on Inflammatory Bowel Diseases", Intestinal research, 13(1), pp.11~18 (2015), 대한장연구학회[DOI]
24. González-Mariscal L, "Role of tight junctions in cell proliferation and cancer", Prog Histochem Cytochem, 42, pp.1~57 (2007)
25. Yoo Jin Lee, "Inflammation, Impaired Motility, and Permeability in a Guinea Pig Model of Postoperative Ileus", Journal of Neurogastroenterology and Motility (JNM), 24(1), pp.147~158 (2018), 대한소화기 기능성질환∙운동학회[DOI]
26. Kim JJ, "Increased TRPV1 and PAR2 mRNA expression levels are associated only with the esophageal reflux symptoms, but not with the extraesophageal reflux symptoms", Medicine (Baltimore), 95, pp.e4387~ (2016)
27. Konstantinopoulos PA, "Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour’s dedifferentiation", Eur J Cancer, 39, pp.1251~1258 (2003)
28. Hee Jin Son, "Effect of Estradiol in an Azoxymethane", Dextran Sulfate Sodium-Treated Mouse Model of Colorectal Cancer: Implication for Sex Difference in Colorectal Cancer Development, 2018, ~[DOI]
29. Harris HA, "Estrogen receptor-beta : recent lessons from in vivo studies", Mol Endocrinol, 21, pp.1~13 (2007)
30. Sun Min Lee, "The Effect of Sex on the Azoxymethane", Dextran Sulfate Sodium-treated Mice Model of Colon Cancer, 2016, pp.21(4), 271~278[DOI]
31. Yum HW, "Oligonol inhibits dextran sulfate sodium-induced colitis and colonic adenoma formation in mice", Antioxid Redox Signal, 19, pp.102~114 (2013)
32. Yo Han Park, "Adequate Dextran Sodium Sulfate-induced Colitis Model in Mice and Effective Outcome Measurement Method", 대한암예방학회지, 20(4), pp.260~267 (2015), 대한암예방학회
33. Kim YS, "Intestinal goblet cells and mucins in health and disease: recent insights and progress", Curr Gastroenterol Rep, 12, pp.319~330 (2010)
34. Ghaleb AM, "Genetic deletion of Klf4 in the mouse intestinal epithelium ameliorates dextran sodium sulfate-induced colitis by modulating the NF-kappaB pathway inflammatory response", Inflamm Bowel Dis, 20, pp.811~820 (2014)
35. Grishina I, "Gender differences, aging and hormonal status in mucosal injury and repair", Aging Dis, 5, pp.160~169 (2014)
36. Son HJ, "17β-Estradiol reduces inflammation and modulates antioxidant enzymes in colonic epithelial cells", Korean J Intern Med (2018)[DOI]
37. Audie JP, "Expression of human mucin genes in respiratory, digestive, and reproductive tracts ascertained by in situ hybridization", J Histochem Cytochem, 41, pp.1479~1485 (1993)
38. Buisine MP, "Developmental mucin gene expression in the human respiratory tract", Am J Respir Cell Mol Biol, 20, pp.209~218 (1999)
39. Gum JR Jr, "Molecular cloning of human intestinal mucin (MUC2) cDNA: identification of the amino terminus and overall sequence similarity to preprovon Willebrand factor", J Biol Chem, 269, pp.2440~2446 (1994)
40. Van der Sluis M, "Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection", Gastroenterology, 131, pp.117~129 (2006)
41. Tadesse S, "MUC2 mucin deficiency alters inflammatory and metabolic pathways in the mouse intestinal mucosa", Oncotarget, 8, pp.71456~71470 (2017)
42. Hsu HP, "Mucin 2 silencing promotes colon cancer metastasis through interleukin-6 signaling", Sci Rep, 7, pp.5823~ (2017)
43. Dhanisha SS, "Mucins: structural diversity, biosynthesis, its role in pathogenesis and as possible therapeutic targets", Crit Rev Oncol Hematol, 122, pp.98~122 (2018)
44. Andrianifahanana M, "Regulation of mucin expression: mechanistic aspects and implications for cancer and inflammatory diseases", Biochim Biophys Acta, 1765, pp.189~222 (2006)
45. Fischer BM, "Neutrophil elastase increases MUC4 expression in normal human bronchial epithelial cells", Am J Physiol Lung Cell Mol Physiol, 284, pp.L671~L679 (2003)
46. Nusrat A, "Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells", Am J Physiol Gastrointest Liver Physiol, 279, pp.G851~G857 (2000)
47. Vetrano S, "Unique role of junctional adhesion molecule-A in maintaining mucosal homeostasis in inflammatory bowel disease", Gastroenterology, 135, pp.173~184 (2008)
48. Ueda J, "Heterogeneous expression of claudin-4 in human colorectal cancer: decreased claudin-4 expression at the invasive front correlates cancer invasion and metastasis", Pathobiology, 74, pp.32~41 (2007)
49. Jin Joo Kim, "Comparison of Tight Junction Protein-Related Gene mRNA Expression Levels between Male and Female Gastroesophageal Reflux Disease Patients", Gut and Liver, 12(4), pp.411~419 (2018), 거트앤리버 소화기연관학회협의회
50. Sun SC, "Non-canonical NF-kappaB signaling pathway", Cell Res, 21, pp.71~85 (2011)
51. Oeckinghaus A, "The NF-kappaB family of transcription factors and its regulation", Cold Spring Harb Perspect Biol, 1, pp.a000034~ (2009)
52. Pai S, "Immune deficiency or hyperactivity-NF-kappaB illuminates autoimmunity", J Autoimmun, 31, pp.245~251 (2008)
53. Liu T, "NF-kappaB signaling in inflammation", Signal Transduct Target Ther, 2, pp.17023~ (2017)
54. Viennois E, "NF-kappaB pathway in colitisassociated cancers", Transl Gastrointest Cancer, 2, pp.21~29 (2013)
55. Schreiber S, "Activation of nuclear factor kappa B inflammatory bowel disease", Gut, 42, pp.477~484 (1998)
56. Greten FR, "IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer", Cell, 118, pp.285~296 (2004)
57. Karban AS, "Functional annotation of a novel NFκB1 promoter polymorphism that increases risk for ulcerative colitis", Hum Mol Genet, 13, pp.35~45 (2004)
58. Atreya I, "NF-kappaB in inflammatory bowel disease", J Intern Med, 263, pp.591~596 (2008)
59. Günal O, "Estradiol treatment ameliorates acetic acid-induced gastric and colonic injuries in rats", Inflammation, 27, pp.351~359 (2003)
60. Harnish DC, "Beneficial effects of estrogen treatment in the HLA-B27 transgenic rat model of inflammatory bowel disease", Am J Physiol Gastrointest Liver Physiol, 286, pp.G118~G125 (2004)
61. Kennelly R, "Oestrogen and the colon: potential mechanisms for cancer prevention", Lancet Oncol, 9, pp.385~391 (2008)
62. Grodstein F, "Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis", Am J Med, 106, pp.574~582 (1999)
63. Campbell-Thompson M, "Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer", Cancer Res, 61, pp.632~640 (2001)
64. Saleiro D, "Estrogen receptor-beta protects against colitis-associated neoplasia in mice", Int J Cancer, 131, pp.2553~2561 (2012)

관련 논문AI추천